CENTENNIAL, Colo., June 17, 2019 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration's (FDA) approval ...

WEYBRIDGE, United Kingdom--(BUSINESS WIRE)--Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, has today announced the release of the Nucleus ® Smart App for Android ™, ...

Cochlear Limited announced yesterday the U.S. Food and Drug Administration clearance of three new products to be added to the company’s suite of hearing technology devices, all of which can connect to ...

Cochlear Ltd., of Sydney, received U.S. FDA approval for its Nucleus Profile Plus cochlear implant and the Nucleus 7 sound processor's new built-in connectivity, enabling direct streaming with ...

Australian company Cochlear has teamed up with Apple to release the world’s first cochlear implant sound processor made for iPhone. The Nucleus 7 sound processor will allow users to stream sounds ...

SYDNEY, Sept 12 (Reuters) - Australian hearing implant maker Cochlear Limited said on Monday it was undertaking a voluntary recall of the unimplanted Nucleus CI500 implant range, with the financial ...

As technology evolves, companies are taking steps to make their tech as inclusive as possible. From motorized lipstick applicators to innovative bone conduction headphones, it's clear that for many ...